Akebia Therapeutics Statistics

Total Valuation

AKBA has a market cap or net worth of $390.54 million. The enterprise value is $459.72 million.

Market Cap	390.54M
Enterprise Value	459.72M

Important Dates

The last earnings date was Thursday, November 7, 2024, before market open.

Earnings Date	Nov 7, 2024
Ex-Dividend Date	n/a

Share Statistics

AKBA has 218.18 million shares outstanding. The number of shares has increased by 9.55% in one year.

Current Share Class	218.18M
Shares Outstanding	218.18M
Shares Change (YoY)	+9.55%
Shares Change (QoQ)	+0.31%
Owned by Insiders (%)	2.61%
Owned by Institutions (%)	24.65%
Float	198.27M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	2.15
Forward PS	2.03
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	2.71
EV / EBITDA	104.25
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.52

Current Ratio	1.52
Quick Ratio	1.01
Debt / Equity	n/a
Debt / EBITDA	10.97
Debt / FCF	n/a
Interest Coverage	-2.61

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-9.37%
Return on Capital (ROIC)	-32.60%
Revenue Per Employee	$1.02M
Profits Per Employee	-$275,401
Employee Count	167
Asset Turnover	0.77
Inventory Turnover	1.38

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +79.00% in the last 52 weeks. The beta is 0.73, so AKBA's price volatility has been lower than the market average.

Beta (5Y)	0.73
52-Week Price Change	+79.00%
50-Day Moving Average	1.54
200-Day Moving Average	1.41
Relative Strength Index (RSI)	55.22
Average Volume (20 Days)	2,439,179

Short Selling Information

The latest short interest is 14.84 million, so 6.80% of the outstanding shares have been sold short.

Short Interest	14.84M
Short Previous Month	17.68M
Short % of Shares Out	6.80%
Short % of Float	7.48%
Short Ratio (days to cover)	8.89

Income Statement

In the last 12 months, AKBA had revenue of $169.88 million and -$45.99 million in losses. Loss per share was -$0.23.

Revenue	169.88M
Gross Profit	142.93M
Operating Income	-33.15M
Pretax Income	-40.44M
Net Income	-45.99M
EBITDA	4.41M
EBIT	-33.15M
Loss Per Share	-$0.23

Full Income Statement

Balance Sheet

The company has $34.02 million in cash and $103.20 million in debt, giving a net cash position of -$69.18 million or -$0.32 per share.

Cash & Cash Equivalents	34.02M
Total Debt	103.20M
Net Cash	-69.18M
Net Cash Per Share	-$0.32
Equity (Book Value)	-50.40M
Book Value Per Share	-0.24
Working Capital	34.41M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$38.50 million and capital expenditures -$31,000, giving a free cash flow of -$38.53 million.

Operating Cash Flow	-38.50M
Capital Expenditures	-31,000
Free Cash Flow	-38.53M
FCF Per Share	-$0.18

Full Cash Flow Statement

Margins

Gross margin is 84.13%, with operating and profit margins of -19.52% and -27.07%.

Gross Margin	84.13%
Operating Margin	-19.52%
Pretax Margin	-27.07%
Profit Margin	-27.07%
EBITDA Margin	2.60%
EBIT Margin	-19.52%
FCF Margin	-22.35%

Dividends & Yields

AKBA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-9.55%
Shareholder Yield	-9.55%
Earnings Yield	-11.78%
FCF Yield	-9.87%

Analyst Forecast

The average price target for AKBA is $5.75, which is 221.23% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$5.75
Price Target Difference	221.23%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	18.40%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

AKBA has an Altman Z-Score of -10.09 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-10.09
Piotroski F-Score	3